The EMT regulator slug and lung carcinogenesis

Carcinogenesis

Volumn 32, Issue 9, 2011, Pages 1299-1304

  Shih, Jin Yuan ^a   Yang, Pan Chyr ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HELIX LOOP HELIX PROTEIN; PROTEIN TYROSINE KINASE INHIBITOR; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; ZINC FINGER PROTEIN;

CANCER GROWTH; CANCER INVASION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 80052403945     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr110     Document Type: Review

References (64)

1. Yang,P. (2009) Epidemiology of lung cancer prognosis: quantity and quality of life. Methods Mol. Biol., 471, 469-486.
2. Non-Small Cell Lung Cancer Collaborative Group. (2010) Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer. Cochrane Database Syst. Rev., 12, CD007309.
3. Lynch,T.J. et al. (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med., 350, 2129-2139.
4. Paez,J.G. et al. (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science, 304, 1497-1500.
5. Janku,F. (2010) Targeted therapy in non-small-cell lung cancer - is it becoming a reality? Nat. Rev. Clin. Oncol., 7, 401-414.
6. Woodhouse,E.C. et al. (1997) General mechanisms of metastasis. Cancer, 80, S1529-S1537.
7. Yoshida,B.A. et al. (2000) Metastasis-suppressor genes: a review and perspective. J. Natl Cancer Inst., 92, 1717-1730.
8. Fidler,I.J. et al. (1977) Metastasis results from preexisting variant cells within a malignant tumor. Science, 197, 893-895.
9. Thiery,J.P. (2002) Epithelial-mesenchymal transitions in tumor progression. Nat. Rev. Cancer, 2, 442-454.
10. Savanger,P. (2001) Leaving the neiborhood: molecular mechanisms involved during eipthelial-mesenchymal transition. Bioessays, 23, 912-923.
11. Singh,A. et al. (2010) EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene, 29, 4741-4751.
12. Edme,N. (2002) Ras induces NBT-II epithelial cell scattering through the coordinate activities of Rac and MAPK pathways. J. Cell Sci., 115, 2591-2601.
13. Jenndahl,L.E. et al. (2005) c-erbB2-induced epithelial-mesenchymal transition in mammary epithelial cells is suppressed by cell-cell contact and initiated prior to E-cadherin downregulation. Int. J. Oncol., 27, 439-448.
14. Thiery,J.P. et al. (2009) Epithelial-mesenchymal transitions in development and disease. Cell, 139, 871-890.
15. Dasari,V. et al. (2006) Epithelial-mesenchymal transition in lung cancer: is tobacco the "smoking gun"? Am. J. Respir. Cell Mol. Biol, 35, 3-9.
16. Thiery,J.P. et al. (2006) Complex networks orchestrate epithelialmesenchymal transitions. Nat. Rev. Mol. Cell Biol., 7, 131-142.
17. Peinado,H. et al. (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer, 7, 415-428.
18. de Herreros,A.G. et al. (2010) Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J. Mammary Gland Biol. Neoplasia, 15, 135-147.
19. Kurrey,N.K. et al. (2009) Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells, 27, 2059-2068.
20. Nieto,M.A. (2002) The snail superfamily of zinc-finger transcription factors. Nat. Rev. Mol. Cell Biol., 3, 155-166.
21. Hemavathy,K. et al. (2000) Snail/slug family of repressors: slowly going into the fast lane of development and cancer. Gene, 257, 1-12.
22. Cobaleda,C. et al. (2007) Function of the zinc-finger transcription factor SNAI2 in cancer and development. Annu. Rev. Genet., 41, 41-61.
23. Tripathi,M.K. et al. (2005) Regulation of BRCA2 gene expression by the SLUG repressor protein in human breast cells. J. Biol. Chem., 280, 17163-17171.
24. Zhou,B.P. et al. (2004) Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol, 6, 931-940.
25. Viñas-Castells,R. et al. (2010) The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation. J. Biol. Chem., 285, 3794-3805.
26. Vernon,A. et al. (2006) Slug stability is dynamically regulated during neural crest development by the F-box protein Ppa. Development, 133, 3359-3370.
27. Wang,S.P. et al. (2009) p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat. Cell Biol., 11, 694-704.
28. Savagner,P. et al. (1998) Slug mRNA is expressed by specific mesodermal derivatives during rodent organogenesis. Dev. Dyn., 213, 182-187.
29. Oram,K.F. et al. (2003) Slug expression during organogenesis in mice. Anat. Rec. A Discov. Mol. Cell. Evol. Biol, 271, 189-191.
30. Perez-Losada,J. et al. (2002) Zinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathway. Blood, 100, 1274-1286.
31. Perez-Mancera,P.A. et al. (2005) SLUG in cancer development. Oncogene, 24, 3073-3082.
32. Alves,C.C. et al. (2009) Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. Front. Biosci., 14, 3035-3050.
33. Shioiri,M. et al. (2006) Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br. J. Cancer, 94, 1816-1822.
34. Shih,J.Y. et al. (2005) Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma. Clin. Cancer Res., 11, 8070-8078.
35. Bolos,V. et al. (2003) The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: acomparison with Snail and E47 repressors. J. Cell Sci, 116(Pt 3), 499-511.
36. Bhat-Nakshatri,P. et al. (2010) SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype. BMC Cancer, 10, 411.
37. Chu,Y.W. et al. (1997) Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am. J. Respir. Cell Mol. Biol., 17, 353-360.
38. Shih,J.Y. et al. (2001) Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells. J. Natl Cancer Inst., 93, 1392-1400.
39. Tsai,M.F. et al. (2006) A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma. J. Natl Cancer Inst., 98, 825-838.
40. Chang,Y.L. et al. (2004) The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Lung Cancer, 44, 149-157.
41. Saito,R.A. et al. (2009) Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells. Cancer Res., 69, 2783-2791.
42. Chen,Y.C. et al. (2008) Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One, 3, e2637.
43. Yang,L. et al. (2007) Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer. Cancer Res., 67, 5587-5593.
44. Jayachandran,A. et al. (2009) SNAI transcription factors mediate epithelial-mesenchymal transition in lung fibrosis. Thorax, 64, 1053-1061.
45. Inukai,T. et al. (1999) SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein. Mol. Cell, 4, 343-352.
46. Perez-Losada,J. et al. (2003) The radioresistance biological function of the SCF/kit signaling pathway is mediated by the zinc-finger transcription factor Slug. Oncogene, 22, 4205-4211.
47. Chen,H. et al. (2009) Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. Cancer Res., 69, 9228-9235.
48. Sakai,D. et al. (2006) Cooperative action of Sox9, Snail2 and PKA signaling in early neural crest development. Development, 133, 1323-1333.
49. Casas,E. et al. (2011) Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res., 71, 245-254.
50. Leong,K.G. et al. (2007) Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of Ecadherin. J. Exp. Med., 204, 2935-2948.
51. Tanno,B. et al. (2010) Expression of Slug is regulated by c-Myb and is required for invasion and bone marrow homing of cancer cells of different origin. J. Biol. Chem., 285, 29434-29445.
52. Ye,Y. et al. (2010) ERalpha signaling through slug regulates E-cadherin and EMT. Oncogene, 29, 1451-1462.
53. Wu,Y. et al. (2009) Small C-terminal domain phosphatase enhances snail activity through dephosphorylation. J. Biol. Chem., 284, 640-648.
54. Wu,Y. et al. (2009) Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell, 15, 416-428.
55. Peinado,H. et al. (2005) A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. EMBO J., 24, 3446-3458.
56. Lim,S.O. et al. (2010) p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma. FEBS Lett., 584, 2231-2236.
57. Wu,W.S. et al. (2005) Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell, 123, 641-653.
58. Mancini,M. et al. (2010) Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells. Cell Signal., 22, 1247-1253.
59. Vitali,R. et al. (2008) Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models. Clin. Cancer Res., 14, 4622-4630.
60. Yauch,R.L. et al. (2005) Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin. Cancer Res., 11, 8686-8698.
61. Witta,S.E. et al. (2006) Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. Cancer Res., 66, 944-950.
62. Chang,T.H. et al. (2011) Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor. Am. J. Respir. Crit. Care Med., 183, 1071-1079.
63. Chung,J.H. et al. (2010) Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs. Lung Cancer Doi 10.1016j.lungcan.2010.11.011.
64. Wang,Y. et al. (2010) Critical role for transcriptional repressor Snail2 in transformation by oncogenic RAS in colorectal carcinoma cells. Oncogene, 29, 4658-4670.